Literature DB >> 16200060

Foveal detachment after successful retinal reattachment for macula on rhegmatogeneous retinal detachment: an ocular coherence tomography evaluation.

S K Gibran1, A Alwitry, P E Cleary.   

Abstract

PURPOSE: Foveal detachment after apparently successful retinal reattachment surgery for macula-on retinal detachments (RDs) has been previously documented. This pilot study aimed to utilize ocular coherence tomography (OCT) imaging to investigate foveal architecture after routine retinal detachment surgery and correlate this to visual acuity.
METHODS: Prospective recruitment of patients attending one unit with macula-on RDs. Patients underwent full clinical examination including OCT preoperatively and RD surgery undertaken by scleral buckling, external drainage and air injection. Postoperatively patients had clinical examinations and OCT at 1 week, 1, 3, 6, and 12 months.
RESULTS: A total of 12 consecutive patients were recruited into the study. All had macula-on RDs and normal OCTs at onset. There were no operative or postoperative complications. Retinal reattachment was achieved in all cases within 24 h postoperatively. At 1 month six of 12 patients (50%) showed foveal detachment on OCT, which was invisible on clinical examination. At 3 months, the foveal detachment persisted in four (33%) of these patients. In these cases the foveal detachment persisted at 6 months follow-up, however, a reduction in subfoveal fluid was noted. All cases had foveal reattachment by 12 months postoperatively. Visual acuity was closely correlated to the presence of foveal attachment. DISCUSSION: A high proportion of patients with successful retinal reattachment surgery had foveal detachments postoperatively. This phenomenon was associated with reduced visual acuity. The aetiology of this occurrence is unknown and warrants further investigation as there is the potential of a long-term effect on vision.

Entities:  

Mesh:

Year:  2005        PMID: 16200060     DOI: 10.1038/sj.eye.6702098

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  6 in total

1.  Vision-related quality of life, metamorphopsia, and stereopsis after successful surgery for rhegmatogenous retinal detachment.

Authors:  G Lina; Q Xuemin; W Qinmei; S Lijun
Journal:  Eye (Lond)       Date:  2015-10-02       Impact factor: 3.775

2.  Persistent submacular fluid diagnosed with optical coherence tomography after successful scleral buckle surgery for macula-off retinal detachment.

Authors:  Igor Kovačević; Aleksandra Radosavljević; Bojan Kalezić; Jelena Potić; Goran Damjanović; Ivan Stefanović
Journal:  Bosn J Basic Med Sci       Date:  2012-08       Impact factor: 3.363

3.  Spectral-domain optical coherence tomography analysis of persistent subretinal fluid after scleral buckling surgery for macula-off retinal detachment.

Authors:  M Gharbiya; R Malagola; C Mariotti; F Parisi; U De Vico; C Ganino; F Grandinetti
Journal:  Eye (Lond)       Date:  2015-07-03       Impact factor: 3.775

4.  Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema.

Authors:  David J Browning; Adam R Glassman; Lloyd P Aiello; Neil M Bressler; Susan B Bressler; Ronald P Danis; Matthew D Davis; Frederick L Ferris; Suber S Huang; Peter K Kaiser; Craig Kollman; Srinavas Sadda; Ingrid U Scott; Haijing Qin
Journal:  Ophthalmology       Date:  2008-08       Impact factor: 12.079

5.  Intravitreal injection of 0.3 ml of SF6 gas for persistent subfoveal fluid after scleral buckling for rhegmatogenous retinal detachment.

Authors:  Hirotaka Itakura; Shoji Kishi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-04-25       Impact factor: 3.117

6.  Selective retina therapy (SRT) of chronic subfoveal fluid after surgery of rhegmatogenous retinal detachment: three case reports.

Authors:  Stefan Koinzer; Hanno Elsner; Carsten Klatt; Erk Pörksen; Ralf Brinkmann; Reginald Birngruber; Johann Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-11       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.